- 2013
-
News in brief - 02.04.2013
Genetic involvement in epilepsy?
A gene involved in so-called “focal” epilepsy, the most frequent form of the condition, has been discovered by the research team directed by Eric Leguern and Stéphanie Baulac of Inserm unit 975 “Genetics and physiopathology of family epilepsy” at the Institut du Cerveau et de la Moelle (ICM) of the Pitié-Salpêtrière Hospital. The researchers studied […]
-
What's on? - 27.03.2013
Publication of the Food Nutritional Composition Table
The table was published by Editions ECONOMICA, through scientific coordination with the NutriNet-Santé and presents the current data concerning the nutritional composition table of food used in the context of the NutriNet-Santé study. Launched in France in May 2009, this study of a prospective observation cohort (www.etude-nutrinet-sante.fr) developed by the INSERM/Inra/Cnam/University of Paris 13 Mixed […]
-
Press releases - 26.03.2013
Hervé Chneiweiss appointed Head of Inserm’s Ethics Committee
Hervé Chneiweiss, a research director at the CNRS, has just been appointed President of the Inserm Ethics Committee. Inserm’s Ethics Committee for medical research and health was set up in 2000 with the aim of playing an active part in the dialogue between Society and the scientific and medical communities.
-
What's on? - 26.03.2013
Contraceptive pills cause 2,500 accidents and 20 dead per annum
According to a report published today by the ANSM (The French National Agency for Medicines and Health Products Safety), between 2000 and 2011, the risk of venous thromboembolism linked to combined oral contraceptives (the pill) is estimated at 2,529 per year, of which 1,751 is attributable to pills of the third and fourth generation. The […]
-
Press releases - 22.03.2013
AgedBrainSYSBIO, a research initiative against neurodegenerative diseases
Un groupe européen de laboratoires s’apprête à combiner la biologie des systèmes intégrés & la génomique comparative afin d’étudier le vieillissement du cerveau humain et/ou les pathologies les plus fréquemment liées à l’âge, avec une attention toute spéciale portée à la maladie d’Alzheimer d’apparition tardive, avec pour but d’identifier et de valider de nouvelles cibles moléculaires et de nouveaux biomarqueurs. Ce programme de recherche de quatre ans est coordonné à l’Inserm par le professeur Michel Simonneau.
-
Press releases - 22.03.2013
Characterisation of the immune cells capable of controlling HIV infection
How is it that certain patients infected by HIV have immune cells that are capable of controlling the infection? Victor Appay, INSERM Research Director (Mixed INSERM Research Unit 945 “ Immunity and Infection” / Université Pierre and Marie Curie / Hôpital Pitié-Salpêtrière (AP-HP)) and his colleagues have succeeded in identifying the molecular characteristics of certain T lymphocytes that have the specific property of being able to detect and control HIV and its mutant versions.
-
Press releases - 21.03.2013
New reference web portal on health research in Europe
The Horizon Health web portal (www.horizonhealth.eu) has been officially launched today. The Horizon Health web portal aims to become a valuable online resource for journalists and interested citizens looking for accurate, up-to-date, and attractive information on health research funded by the EU
-
What's on? - 20.03.2013
March: Sleep Day
Celebrated in France and throughout the world, sleep day will be held on Friday, 22 March on the subject of “Sleep and Environment”. This day is an opportunity to learn more about the benefit of sleeping, talking to doctors and researchers and meeting patients’ associations, etc. For this international day, the experts of Inserm, the […]
-
News in brief - 18.03.2013
HTAP: discovery of a genetic market associated with increased risk
A genetic marker localised on chromosome 18 is associated with a doubling of the risk of pulmonary arterial hypertension (PAH). A gene close to this marker is suspected of being responsible for an increased risk of the disease, according to an academic study (letter) published in Nature Genetics* on 17 March 2013. PAH is a […]
-
News in brief - 18.03.2013
Genetic mutation and the prognosis for renal polycystosis
The team headed by Claude Férec, director of INSERM 1078 “Genetics, functional genomics and biotechnologies” (INSERM/Université de Bretagne/EFS) in Brest, published results in the Journal of the American Society of Nephrology from a cohort of 700 patients suffering from Autosomal Dominant Polycystic Kidney Disease (ADPKD). This condition, the most frequent monogenetic hereditary kidney disease, manifests through […]